Although rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-
CHOP) is the standard treatment for patients with diffuse large B-cell lymphoma (DLBCL),∼ …

Despite considerable advances in the treatment of lymphoma, the prognosis of patients with
relapsed and/or refractory disease continues to be poor; thus, a continued need exists for …

MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression mainly at
the posttranscriptional level. Similar to protein-coding genes, their expression is also …

MicroRNAs (miRNAs) are a well‐studied group of noncoding RNAs that control gene
expression by interacting mainly with messenger RNA. It is known that miRNAs and their …

Introduction Lymphoma is a common canine cancer with translational relevance to human
disease. Diffuse large B-cell lymphoma (DLBCL) is the most frequent subtype, contributing …

Background The prognostic value of aberrant DNA methylation of cell-free circulating DNA
in plasma has not previously been evaluated in diffuse large B cell lymphoma (DLBCL). The …

Lymphoma is the most common hematopoietic tumour in dogs and is remarkably similar to
the human disease. Tumour biomarker discovery is providing new tools for diagnostics and …

Lymphomas are a group of hematological malignancies derived from lymphocytes.
Lymphomas are clinically and biologically heterogeneous and have overlapping diagnostic …

Benzene is a common environmental pollutant that causes hematological alterations.
MicroRNAs (miRNAs) may play a role in benzene-induced hematotoxicity. In this study …

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's
lymphoma. Improvements in overall survival have been observed with the introduction of …